IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Contract Fine Chemicals: Hindsight

9:50 AM MDT | March 15, 2010 |

Guy Villax

CEO of Hovione For most of this decade we have been told that the number of new drug approvals by FDA is decreasing. An article published in Nature in December 20091 sheds new light on this. Bernard Munos researched the last 60 years of drug approvals. 1222 NME were approved by FDA since 1958 – and its conclusions are startling: 1.       There was no reduction of NME approvals since the Nineties, instead what occurred in the 2nd half of the 90s was an unusually large number of approvals. One more reason for the flood of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa